Literature DB >> 27109139

Synergistically increased ILC2 and Th9 cells in lung tissue jointly promote the pathological process of asthma in mice.

Xinyu Ying1, Zhaoliang Su1, Qingli Bie1, Pan Zhang1, Huijian Yang1, Yumin Wu1, Yunyun Xu1, Jing Wu1, Mengying Zhang1, Shengjun Wang1, Huaxi Xu1.   

Abstract

In recent years, T helper (Th) 9 cells have been demonstrated to be key mediators in immune responses in asthmatic lungs, and innate lymphoid cells 2 (ILC2s) have been described as a novel type of innate immunocyte with the ability to enhance immunoglobulin E (IgE) production. However, the interaction between ILC2s and Th9 cells in the pulmonary system of a mouse model of asthma remains to be elucidated. In the present study, the response state of lung tissue with regards to Th9 and ILC2s in a mouse model of asthma was investigated by detecting Th9‑ and ILC2‑associated cytokine receptors. The present study also investigated the association between the expression levels of the cytokine receptors in lung tissue samples and the IgE levels in sera samples from mouse models of asthma. Results from the present study demonstrated that the frequency of ILC2s and Th9 cells was significantly increased in the lung tissue samples, indicating that a Th2-type immune response had occurred. In addition, high mRNA expression levels of RAR‑related orphan receptor α, interleukin 1 receptor‑like 1, transcription factor PU.1 and interleukin (IL)‑9 were observed. Furthermore, IL‑5Rα, IL‑13Rα2 and high‑affinity IgE receptor were increased in mouse models of asthma, and a positive association was observed between the expression levels of ILC2‑ or Th9‑associated receptors in tissue samples and IgE levels in the sera. This indicated that ILC2s and Th9 were in a state of polarization and may promote each other in the lung tissue of mouse models of asthma, and that the lung tissue was responding to the two types of cells via increased expression of receptors.

Entities:  

Mesh:

Year:  2016        PMID: 27109139     DOI: 10.3892/mmr.2016.5174

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  10 in total

1.  Therapeutic Effect of Renifolin F on Airway Allergy in an Ovalbumin-Induced Asthma Mouse Model In Vivo.

Authors:  Zhuya Yang; Xiaohong Li; Rongbing Fu; Min Hu; Yijie Wei; Xuhong Hu; Wenhong Tan; Xiaoyun Tong; Feng Huang
Journal:  Molecules       Date:  2022-06-12       Impact factor: 4.927

Review 2.  The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung.

Authors:  Florian Wirsdörfer; Verena Jendrossek
Journal:  Front Immunol       Date:  2016-12-14       Impact factor: 7.561

Review 3.  Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung.

Authors:  Hang Cheng; Chengyan Jin; Jing Wu; Shan Zhu; Yong-Jun Liu; Jingtao Chen
Journal:  Protein Cell       Date:  2017-03-07       Impact factor: 14.870

Review 4.  Radiation recall pneumonitis induced by PD-1/PD-L1 blockades: mechanisms and therapeutic implications.

Authors:  Feifei Teng; Min Li; Jinming Yu
Journal:  BMC Med       Date:  2020-09-18       Impact factor: 8.775

5.  Butyrate Attenuates Lung Inflammation by Negatively Modulating Th9 Cells.

Authors:  Raquel de Souza Vieira; Angela Castoldi; Paulo José Basso; Meire Ioshie Hiyane; Niels Olsen Saraiva Câmara; Rafael Ribeiro Almeida
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

6.  Single-cell analysis of RORα tracer mouse lung reveals ILC progenitors and effector ILC2 subsets.

Authors:  Maryam Ghaedi; Zi Yi Shen; Mona Orangi; Itziar Martinez-Gonzalez; Lisa Wei; Xiaoxiao Lu; Arundhoti Das; Alireza Heravi-Moussavi; Marco A Marra; Avinash Bhandoola; Fumio Takei
Journal:  J Exp Med       Date:  2020-03-02       Impact factor: 14.307

7.  Anti-ST2 Nanoparticle Alleviates Lung Inflammation by Targeting ILC2s-CD4+T Response.

Authors:  Yumin Wu; Weifeng Shi; Honghai Wang; Jiawei Yue; Yijie Mao; Wei Zhou; Xinagmin Kong; Qiqiong Guo; Lirong Zhang; Pengxiao Xu; Yuyue Wang
Journal:  Int J Nanomedicine       Date:  2020-12-03

8.  Modified BuShenYiQi formula alleviates experimental allergic asthma in mice by negative regulation of type 2 innate lymphoid cells and CD4+ type 9 helper T cells and the VIP-VPAC2 signalling pathway.

Authors:  Muhua Huang; Jinfeng Wu; Jingcheng Dong
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

9.  Analysis of the levels of Th9 cells and cytokines in the peripheral blood of mice with bronchial asthma.

Authors:  Ruifang Tong; Liping Xu; Lihong Liang; Han Huang; Rui Wang; Yinghui Zhang
Journal:  Exp Ther Med       Date:  2018-01-04       Impact factor: 2.447

Review 10.  Immunological Aspect of Radiation-Induced Pneumonitis, Current Treatment Strategies, and Future Prospects.

Authors:  Anup Kainthola; Teena Haritwal; Mrinialini Tiwari; Noopur Gupta; Suhel Parvez; Manisha Tiwari; Hrideysh Prakash; Paban K Agrawala
Journal:  Front Immunol       Date:  2017-05-02       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.